Boothbay Fund Management, LLC Gilead Sciences, Inc. Call Options Transaction History

Boothbay Fund Management, LLC

4 transactions

Quarter	Operation	Price Per call	calls change	calls Held
Q2 2023 Aug 14, 2023	BUY	$76.01 - $86.7 $11.2 Million - $12.8 Million	147,600 New	147,600 $11.4 Million
Q3 2022 Nov 14, 2022	BUY	$59.54 - $68.01 $232,206 - $265,239	3,900 New	3,900 $241,000
Q1 2022 May 16, 2022	BUY	$57.92 - $72.58 $1.11 Million - $1.39 Million	19,100 Added 222.09%	27,700 $1.65 Million
Q2 2021 Aug 16, 2021	BUY	$63.47 - $69.35 $545,842 - $596,410	8,600 New	8,600 $592,000

1,927

994M

10.5M

9.75M

Ticker GILD
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 1,253,369,984
Market Cap $116B
Description
Gilead Sciences, Inc., a biopharmaceutical company, discovers, develops, and commercializes medicines in the areas of unmet medical need in the United States, Europe, and internationally. The company provides Biktarvy, Genvoya, Descovy, Odefsey, Truvada, Complera/ Eviplera, Stribild, and Atripla products for the treatment of HIV/AIDS; Veklury, a...

Get notified when there are updates to the investment portfolio of Boothbay Fund Management, LLC, based on Form 13F filings with the SEC.

Stay updated on Boothbay Fund Management, LLC with notifications on news.